CAMBRIDGE, Mass., June 6, 2013 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that William Sullivan, CFO, is scheduled to present at the Goldman Sachs 34 th Annual Global Healthcare Conference on Thursday, June 13, 2013 at 8:00 a.m. (PT) at the Terranea Resort in Rancho Palos Verdes, California.
A live webcast of Merrimack's presentation can be accessed by visiting the Investors section of the company's website at investors.merrimackpharma.com. A replay of the webcast will be archived on Merrimack's website for two weeks following the presentation.
About MerrimackMerrimack is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. Merrimack applies its systems biology-based approach to biomedical research throughout the research and development process. Merrimack currently has six oncology therapeutics in clinical development. Forward-looking statements Any statements in this press release about future expectations, plans and prospects for Merrimack constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended. Actual results may differ materially from those indicated by such forward-looking statements. Merrimack anticipates that subsequent events and developments will cause its views to change. However, while Merrimack may elect to update these forward-looking statements at some point in the future, Merrimack specifically disclaims any obligation to do so.
CONTACT: Media Contacts: Kathleen Petrozzelli Gallagher, Merrimack 617-441-1043 email@example.com Liz Bryan, Spectrum 202-955-6222 firstname.lastname@example.org